This application will attempt to derive HIV structural gene vectors (SGV) and to evaluate their infectivity and immunogenicity both in vitro and in vivo. The investigator will define the minimal combination of HIV accessory genes that are required for efficient replication in cultured and in primary human T-cells and in primary monkey T-cells and finally to evaluate infectivity and immunogenicity of SIV SGV in the macaque model.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI046325-02
Application #
6170687
Study Section
Special Emphasis Panel (ZRG1-VACC (01))
Program Officer
Bradac, James A
Project Start
1999-08-01
Project End
2003-07-31
Budget Start
2000-08-01
Budget End
2003-07-31
Support Year
2
Fiscal Year
2000
Total Cost
$219,000
Indirect Cost
Name
Ohio State University
Department
Veterinary Sciences
Type
Schools of Veterinary Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Boris-Lawrie, K; Roberts, T M; Hull, S (2001) Retroviral RNA elements integrate components of post-transcriptional gene expression. Life Sci 69:2697-709
Pandya, S; Boris-Lawrie, K; Leung, N J et al. (2001) Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system. Hum Gene Ther 12:847-57